#Cord Blood Banking Service Market

[comparableau]

Cord Blood Banking Services Market is expected to grow at a CAGR of 10% over the forecast period (2021-2027)

[luckydige45]

As per the report from nova one advisor, the global U.S. cord blood banking services market is valued at USD 8.48 billion in 2023 and is projected to reach a value of USD 22.71 billion by 2032 at a CAGR of 11.57% between 2023 and 2032

[kristinahertzz]

Cord Blood Banking Services Market

Cord Blood Banking Services Market Size, Share, Trends: Cord Blood Registry (CBR) Systems Leads

Growing Demand for Regenerative Medicine Fuels Market Expansion

Market Overview: 

The global Cord Blood Banking Services Market is projected to grow significantly from 2024 to 2031. North America currently dominates the market, followed by Europe and Asia-Pacific. Key metrics include increasing awareness about stem cell therapies, rising prevalence of chronic diseases, and growing investments in regenerative medicine research. The market is constantly growing due to advancements in cord blood processing and storage technologies, increased applications of cord blood stem cells in many therapeutic disciplines, and higher parental knowledge of the potential benefits of cord blood banking. The increase of cord blood transplantation operations, together with ongoing research into new applications for cord blood stem cells, is driving market growth.

DOWNLOAD FREE SAMPLE

Market Trends: 

The cord blood banking business is witnessing a substantial shift towards hybrid banking models that incorporate components of both commercial and public banking. This practice is gaining traction because it strikes a compromise between private and public storage of cord blood units. Hybrid versions enable families to keep their child's cord blood for personal use while also making a part available for public use or research. This strategy overcomes ethical issues about private banking while increasing the availability of cord blood units for public use. Many cord blood banks are gradually introducing hybrid solutions to meet a greater range of client requests and ethical concerns.

Market Segmentation: 

Private cord blood banking services are the industry's largest section, accounting for more than 60% of the total. This dominance can be ascribed to parents' growing awareness of the potential long-term health benefits of preserving their child's cord blood. Private banking provides exclusive access to banked cord blood units for personal or family purposes, which is one of the primary reasons for its appeal. Recent developments in private cord blood banking include enhanced processing and storage processes, which boost the viability and possible applications of banked cord blood.

Market Key Players: 

Prominent players in the Cord Blood Banking Services Market include Cord Blood Registry (CBR) Systems, Cryo-Cell International, ViaCord, Cordlife Group Limited, Cryo-Save AG, LifeCell International Pvt. Ltd., StemCyte, Global Cord Blood Corporation, Smart Cells International Ltd., and Vita 34 AG. These companies are at the forefront of the industry, continuously innovating and expanding their product portfolios to meet the evolving market demands. Their strategic initiatives and robust distribution networks have enabled them to maintain a strong market presence and drive growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[dtgmarketreport]

Blood Bank Market Size & Forecast 2025-2035

The global Blood Bank market, estimated to be valued at USD 21.85 billion in 2024, is estimated to grow up to USD 41.05 billion by 2035 with a CAGR of 5.9% in the period from 2025 to 2035. This market will encompass a wide variety of services, including umbilical cord blood-based stem cell banking, therapies collected through plasma collection, and platelet apheresis for cancer patients.

Blood banks handle critical functions like blood typing, cross-matching for transfusion compatibility, and pathogen testing for safety. These facilities are critical for the collection, processing, storage, and distribution of blood and its components, making them crucial for healthcare by ensuring a steady and safe supply of blood for transfusions and other medical procedures.

Market Dynamics

Mobile Blood Donation units increase mobilization

Mobile blood donation units are changing the face of blood donation. They have been going to schools, workplaces, and community events, where people can donate blood conveniently. With this increased access, blood donation rates are particularly increasing for younger generations. Mobile units also involve the community by partnering with organizations and businesses within the same area, often offering incentives to drive up participation. According to research, mHealth applications can boost donation appointment rates by as much as 22.7%. This could save hundreds of thousands of lives every year.

Challenges of Short Shelf Life for Blood Products

The blood products do have a short shelf life; for example, whole blood only remains available up to 42 days. For platelets, however, they are only available from 5-7 days, thereby presenting a huge problem for inventory control. Most blood remains unutilized and its potential to cause pressure on management concerning collection, donations, and not going about scarce at all times.

AI-Enhanced Blood Management Solutions

Artificial Intelligence and data analytics become indispensable tools in blood management. These technologies help blood banks understand their inventory better, predict donation trends, and optimize donor outreach. Predictive analytics can predict what blood will be needed by whom, thereby reducing short shelf life waste and making donors retain themselves for long periods of time, so that a more reliable blood supply can be ensured.

Expert opinions

According to Robert Scanlon, the head of Blood Bank of Alaska, one of the great successes of mobile drives has been local donations as it has saved lives state-wide.

Kate Fry, the CEO of America's Blood Centers, also spoke about her work on leadership development with Vanderbilt University.

Get A Free Sample Report @Click Here

Market Segmentation

Product Type

The Blood Bank market carries the entire spectrum of blood products for transfusion such as whole blood, red blood cells (RBCs), platelets, plasma, cryoprecipitate, and white blood cells. Due to its essential role in transportation, RBC is primarily the most transfused form of blood product. Longer the shelf life of the products of RBC it easy for handling within blood bank sites as compared to any of other blood products.

Function Type

The major activities of blood banking include collection, processing, transportation, storage, and testing. Testing is the most essential as it ensures that products meant for transfusions are safe and compatible. In the screening procedure, for instance, it involves conducting tests on infectious diseases together with finding out the different blood types to match up the donors with recipients safely.

Regional Analysis

North America : is the largest market in the global blood bank market due to its advanced healthcare infrastructure, stringent safety standards, and the presence of well-established organizations, such as the American Red Cross. Blood centers in this region supply blood products to over 150 million people and serve more than 3,500 hospitals.

Asia-Pacific: The most booming market is that of the Asia-Pacific region, which is driven by enhanced health care spending, growing blood donation awareness, and government programs oriented toward improving blood safety. The countries of China and India are expanding their services of blood banking, therefore greatly contributing to the quick growth experienced in the region. Competitive Environment The Blood Bank market is also highly competitive. Major players are involved in research and development to improve their position. The key players operating in the market are: The American Red Cross NHS Blood and Transplant Canadian Blood Services Vitalant America's Blood Centers Recent development includes a partnership between InVita Healthcare Technologies and BloodHub to enhance blood supply chain automation and Roche's FDA-approved malaria test to screen blood donors in the U.S. Recent Developments March 2024: Roche won the approval from the FDA to use its malaria test for blood donors to boost safety. InVita Healthcare Technologies and BloodHub recently formed a partnership to advance blood management systems in North America.

Conclusion :

 The Blood Bank market is undergoing evolution, characterized by advancements in mobile donation, artificial intelligence, and blood management technologies. Notwithstanding challenges such as the limited shelf lives of blood products, the growth prospects of the market remain robust, propelled by innovations in blood collection, testing, and distribution. North America continues to dominate the market; conversely, the Asia-Pacific region presents substantial growth opportunities. Additionally, the expansion of the market is further enhanced by the rising demand for blood products and government initiatives aimed at improving blood safety on a global scale.

[rameshindustryarc]

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 (𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐃𝐅)-IndustryARC™

The Stem Cell Market refers to the global industry focused on the research, development, production, and commercialization of products and therapies derived from stem cells. This market encompasses a wide range of applications, from regenerative medicine and drug discovery to tissue engineering and disease modeling. Stem cells are unique because they can develop into various specialized cell types and are capable of self-renewal, making them highly valuable in medical research and treatment.

🔗 𝑫𝒐𝒘𝒏𝒍𝒐��𝒅 𝑺𝒂𝒎𝒑𝒍𝒆 𝑹𝒆𝒑𝒐𝒓𝒕

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐌𝐚𝐫𝐤𝐞𝐭:

𝐓𝐲𝐩𝐞𝐬 𝐨𝐟 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥𝐬:

Embryonic Stem Cells (ESCs): Derived from early-stage embryos and can differentiate into any cell type.

Adult Stem Cells: Found in specific tissues, such as bone marrow or adipose tissue, with a more limited differentiation potential.

Induced Pluripotent Stem Cells (iPSCs): Adult cells reprogrammed to behave like embryonic stem cells.

Hematopoietic Stem Cells (HSCs): Found in bone marrow and used in treatments for blood disorders.

Mesenchymal Stem Cells (MSCs): Found in bone marrow, fat, and other tissues, used in regenerative therapies.

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

Regenerative Medicine: Repairing or replacing damaged tissues and organs.

Drug Discovery and Testing: Using stem cells to model diseases and test drug efficacy.

Cancer Treatment: Stem cell transplants for blood cancers like leukemia.

Neurological Disorders: Potential therapies for conditions like Parkinson's or spinal cord injuries.

Tissue Engineering: Development of bioengineered tissues and organs.

Products and Services:

Stem cell therapies and transplants.

Research products, including reagents, kits, and culture systems.

Equipment for stem cell isolation, expansion, and storage.

Banking services for storing stem cells (e.g., cord blood banking).

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Growing prevalence of chronic and degenerative diseases.

Advancements in stem cell research and technology.

Increased funding from governments and private sectors.

Rising demand for personalized medicine.

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

Ethical concerns, particularly with embryonic stem cells.

High costs of research and therapies.

Regulatory hurdles and standards.

Limited awareness in developing regions.

[marketingreportz]

Stem Cell Banking Market - Forecast(2024 - 2030)

Stem Cell Banking Market Overview

Request sample Report :

The ongoing research in stem cells has the capability to understand how diseases occur, and various conditions develop. Cord tissue banking has been adopted as the potential method to store life-saving stem cells for any future injuries or chronic diseases. The advent of regenerative medicines and the use of stem cells to check quality and safety before releasing a new batch of drugs have been key factors driving the stem cell banking industry forward in the projected period of 2021–2026.

Report Coverage

The report: “Stem Cell Banking Market Forecast (2021–2026)” by Industry ARC covers an in-depth analysis of the following segments of the Stem Cell Banking Market.

By Source- Placental Stem Cell, Adipose-Tissue Derived Stem Cells, Bone Marrow-Derived Stem Cells, Human Embryo Derived Stem Cell, Dental Pulp Derived Stem Cells and Others.

By Service Type- Sample Preservation and Storage, Sample Analysis, Sample Processing, and Sample Collection and Transportation.

By Application- Personalized Banking, Research Applications, and Clinical Applications.

By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Inquiry Before Buying :

Key Takeaways

Geographically, North America’s stem cell banking held a dominant market share in the year 2020. It is owing to the advent of various genetic disorders and the rise in the use of regenerative medicines. Additionally, the region is seeing an inflated flow of funds for development pertaining to the pharmaceutical and biotechnology sector which has readily aided the market growth. However, Asia-Pacific is set to grow at a lucrative pace in the projected period. It is owing to the development of new-age start-ups which thereby allows for the opening of various stem cell banking systems using advanced healthcare technology such as IoT.

The growing awareness pertaining to the use of therapeutic potential stem cells has been a key driver for the market. However, high operational costs and maintenance fees are some of the reasons the market is facing friction and poses a challenge.

A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the stem cell banking market report.

Stem Cell Banking Market- Geography (%) for 2020.

For more details on this report — Request for Sample

Stem Cell Banking Market Segmentation Analysis- By Source

The stem cell banking market based on the source can be further segmented into Placental Stem Cell, Adipose-Tissue Derived Stem Cells, Bone Marrow-Derived Stem Cells, Human Embryo Derived Stem Cell, Dental Pulp Derived Stem Cells and Others. The Bone marrow-derived stem cells held a dominant market share in the year 2020. It is owing to its standard use in the treatment of cancer cases such as leukemia, myeloma, and various others. Bone marrow-derived stem cells are also considered privileged immune cells, as they do not portray immunogenic properties and hence are used in patients who then do not need immunosuppression. Moreover, there are close to 4300 bone marrow and cord blood transplants recorded in 2018, while nearly 23 million potential donors are available.

However, Human Embryo Stem cells are estimated to be the fastest-growing, with a CAGR of 8.4% over the forecast period of 2021–2026. The embryonic stem cell is obtained potentially after 3–5 days, and it has about 150 cells. Moreover, the following pluripotent stem cells have the capability to divide into more stem cells or become any form of cell. Their versatility has allowed the researchers to use them in various applications pertaining to regenerative medicines or to especially regenerate a diseased tissue or organ.

Schedule A Call :

Stem Cell Banking Market Segmentation Analysis- By Application

The stem cell banking based on the application can be further segmented into Personalized Banking, Research Applications, and Clinical Applications. Personalized banking held a dominant market share in the year 2020. It is owing to the various benefits now being co-offered with availing services. The service provider has curated various flexible payment plans to later the financial burden on the end-user. For example, Cord Blood Registry has payment plans starting from as low as $49/month. Additionally, they have started promoting themselves under “highest recovery rate- up to 99%”, which readily appeals to the public’s confidence, as recovery is often a worry in cases of stem cell banking.

Moreover, personalized banking is estimated to be the fastest-growing, with a CAGR of 8.6% over the forecast period of 2021–2026. The advent of insurance policies in the service provider has proved out to be a game-changer. Sample banking companies reimburse in cased of failed graft, however owing to competition, the bankers have really notched up their payback rates. For example, Ameri-Cord now pays around $110,000 as insurance, with no monthly storage fees and cancellation fees. The following methodology would drive the segment forward.

Stem Cell Banking Market Segmentation Analysis- By Geography

The Stem Cell Banking Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America’s stem cell banking held a dominant market share of 42% as compared to the other regions in 2020. It is owing to the rising cases of cancers and other neurodegenerative diseases in the region. For example, in the U.S., approximately 1.9 million were diagnosed with Cancer; moreover, post-cancer stem cell therapy is often recommended as it helps in restoring the damaged cells. The cells are damaged owing to chemotherapy and other forms. Along with that, the incidence of Parkinson’s disease is high in the country, and the ongoing research has helped the market of stem cell banking across various applications.

However, Asia-Pacific is set to offer lucrative market opportunities to marketers in the projected period of 2021–2026. It is owing to a steady rise in the new players opting for facilities such as stem cell banking. Additionally, governmental agencies have supported the start-up culture in the health care domain, which allows for the development of new drugs, which again supports the growth of stem cells. These factors would help in the growth of the following region.

Stem Cell Banking Market Drivers

The use of stem cell therapy or regenerative medicines has readily aided market growth.

Stem cell therapy has often been conferred as the next chapter after organ transplantation. As they are termed regenerative medicines, they promote repair response in the diseased cells. The following cells are used instead of donor’s organs, as they have the potential to provide a healthy line of cells that are free of any disease or infection. Researchers grow these cells in their labs and are thereby manipulated to form other forms of distinctive cells. For example, if a patient is suffering from heart disease, then they can be used and injected into the heart muscle. The healthy line of cells could repair the defective heart cells and contribute to a better life expectancy. Stem cell therapy can readily suffice the demand and supply gap between organ transplants. For example, the demand for a kidney transplant in the USA was close to 100,000; however, only close to 20,000 people received the transplant. The demand for the remaining can be catered by stem cell therapy, and hence, grow the stem cell banking market.

Buy Now :

The lateral increase in auto-immune diseases and the elongated use of stem cells to check for effectiveness in new drugs have readily aided the growth of the market.

Stem cell therapy has shown results in treating those afflicted with spinal cord injuries, suffering from type 1 diabetes, Parkinson’s disease, and various other rare diseases. As per Parkinson’s Organization, approximately more than 60,000 cases of the disease are added in the USA. Moreover, there are currently more than one million-plus active cases of the disease in the demography. Researchers are readily studying the use of stem cell therapy in the treatment of Parkinson’s disease. Stem cells can be directly injected into the brains of people, and a doctor must make a small incision and inject stem cells where the neurotransmitter dopamine is found. The process can take hold and thereby start producing dopamine which is negligible in the person suffering from Parkinson’s disease. Lastly, the cost of such treatment would be on the lower side and hence allow more people to take advantage of it.

Stem Cell Banking Market Challenges

The operational cost pertaining to storage and other facilities has acted as a market challenge.

The stem cells or the embryonic stem cells are often derived from the umbilical cord. A lot of competition has already been in place for the market. However, the cost of storing stem cells in a bank remains a primary concern. The pricing for storing cord tissue or stem cells, on average, can cost $4000/ a year. Additionally, facilities always face the risk of losing the sample’s integrity owing to various physical constraints. The reagents, consumables, and other instruments are charged on premium, which in turn increases the per-person cost. The process for acquiring licenses has been another challenge as regulatory bodies follow a stringent approach. Hence, the number of providers and new entrants are not many, and hence poses a market challenge.

Stem Cell Banking Market Competitive Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the stem cell banking. The top 10- stem cell banking market companies include:

Cord Blood Registry

Americord

CryoCell

StemCyte

Viacord

Lifebank USA

Miracle Cord

Maze Cord Blood

CryoHoldco

CordLife Group Limited

Stem Cell Banking Market Developments

In September 2021, The California Institute for Regenerative Medicines awarded $31 million to Stanford Researchers. The amount is granted to study stem cells and conduct the first-in-human trials of stem cells to treat stroke, heart failure, and other forms of neurodegenerative diseases. The $31 million is divided into various other purposes, for example, $12 million would allow for the study, whether after therapy with stem cell one can regain mobility. The second study, in which $ 12 million would be used to study CAR-T cell therapy. Another, $7 million is to be used to study stem cells’ ability to help in aiding heart failures.

In January 2020, Life-Cell launched community stem cell banking services in India. The enterprise would be known as Baby Cord Share. The purpose of the launch was to allow for the ready availability of finding a matching donor in a challenging environment. The price to avail of the services is kept at INR 17000, while an annual maintenance fee of INR 4,000 would be charged from the customer.

Relevant Titles

Tissue Banking Market — Forecast (2021–2026)

Report Code- HCR 0014

Extremity Tissue Expanders Market- Forecast (2021–2026)

Report Code- HCR 1448

For more Lifesciences and Healthcare related reports, please click here

[waquasuniverse]

Cord Blood Banking Services Market To Reach $41.36Bn By 2030

The global cord blood banking services market size is expected to reach USD 41.36 billion by 2030, registering a CAGR of 7.4% during the forecast period, according to a new report by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapies in disease treatment, and rising prevalence of life threatening genetic disorders. Moreover, increasing…

[wellnessweb]

Global Mesenchymal Stem Cells Market Overview

The Mesenchymal Stem Cells Market size was estimated at USD 3.11 billion in 2023 and is expected to reach USD 8.22 billion by 2031 with a growing CAGR of 12.93% during the forecast period of 2024-2031.The Mesenchymal Stem Cells (MSCs) market is poised at the intersection of groundbreaking research and therapeutic innovation, heralding a new era in regenerative medicine.

With their remarkable potential to differentiate into various cell types, MSCs have captivated the biomedical field, offering promising avenues for treating a spectrum of diseases from orthopedic injuries to autoimmune disorders. As scientific understanding deepens and clinical trials expand, the market for MSC therapies anticipates exponential growth, driven by robust investment in biotechnology and increasing healthcare demand for effective, personalized treatments. This burgeoning market not only holds the key to transformative therapies but also represents a pivotal frontier in harnessing the body's own healing mechanisms for improved patient outcomes worldwide.

Get Sample Report @ https://www.snsinsider.com/sample-request/3948

Market Scope & Overview

The most recent Mesenchymal Stem Cells Market  report offers accurate data on the market's size, share, and capacity for production, demand, and growth over the coming year. According to market research, the market is changing quickly, and both the impact on the present and the future are being examined. The market research team conducted thorough primary and secondary research to gather the relevant market data.

The market size and value for each industry, channel, and other sector are discussed in the research. It also takes into account the elements and traits that could affect the expansion of the market's sales. The market's present and future states are carefully examined in the worldwide Mesenchymal Stem Cells Market  research report.

Market Segmentation Analysis

By Products and Services

Products

Cells & Cell Lines

Kits, Media, & Reagents

Others

Services

By Workflow

Cell Sourcing & Isolation

Culture & Cryopreservation

Differentiation

Characterization

By Type

Autologous

Allogeneic

By Source of Isolation

Bone Marrow

Cord Blood

Peripheral Blood

Fallopian Tube

Fetal Liver

Lung

Adipose Tissues

By Indication

Bone And Cartilage Repair

Cardiovascular Disease

Inflammatory And Immunological Diseases

Liver Diseases

Cancer

GvHD

Others

By Application

Disease Modelling

Drug Development & Discovery

Stem Cell Banking

Tissue Engineering

Toxicology Studies

Others

COVID-19 Impact Analysis

The worldwide economy is significantly impacted by the coronavirus outbreak. The most recent COVID-19 scenario analysis is included in this Mesenchymal Stem Cells Market  research report. The top businesses, distributors, and supply chain organizations in the sector are also examined in the report.

Regional Outlook

North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are the five geographic divisions of the market. The Mesenchymal Stem Cells Market report examines each regional market in great detail and sheds light on the key factors influencing it. The research takes into account factors such as market size and share, import/export ratios, supply/demand ratios, consumer demand ratios, technological advancements, R&D, infrastructure development, and a strong market presence across the board.

Competitive Analysis

To give readers a greater understanding of the important players, the study report covers cutting-edge research approaches including SWOT and Porter's Five Forces analysis. Additionally, it includes crucial data on the economy, global positioning, product portfolios, earnings, gross profit margins, and scientific and technology advancements. The key industry partnerships, product launches, and acquisitions are the subject of the Mesenchymal Stem Cells Market  research.

Key Reasons to Purchase Mesenchymal Stem Cells Market  Research Report

Market research contains critical development status, growth rates, evaluations of the competitive environment, and data on international marketing.

The research report offers a comprehensive view of the worldwide competitive climate as well as crucial details on the leading rivals and their projected future growth.

Conclusion

For industry participants and other stakeholders looking for a thorough analysis of the current market dynamics as well as realistic estimates, the Mesenchymal Stem Cells Market  research report will be a valuable resource.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in re framing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Nasal Drug Delivery Market Growth Drivers

DNA Synthesis Market Growth Drivers

Osteoporosis Treatment Market Growth Drivers

Immunomodulators Market Growth Drivers

Proteomics Market Growth Drivers

[yashmedica]

Cord Blood Banking: Your Questions Answered - A Comprehensive Guide

Considering cord blood banking? This guide answers your top questions about applications, success rates, ethical considerations, and exciting advancements from leading companies. Make informed decisions for your family's health

Cord Blood Banking Services: Top Questions Answered About Applications and Innovations Cord blood banking offers a potential lifeline for treating various medical conditions. However, it can be confusing to navigate the process. This guide explores key questions regarding cord blood applications, success rates, and cutting-edge advancements in the Cord Blood Banking Services Market from leading…

[healthcaremarketanalysis]

Biobanking Market worth $5.0 billion by 2028

Biobanking Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood banks has led to a rise in competition among biobanks, which has driven innovation and improvements in the quality of biobanking services. This, in turn, has fueled growth in the biobanking market as more companies seek to enter this expanding field and meet the growing demand for cord blood stem cell preservation.

Browse in-depth TOC on "Biobanking Industry"

334 - Tables

48 - Figures

398 – Pages.

Download PDF Brochure:

The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood banks has led to a rise in competition among biobanks, which has driven innovation and improvements in the quality of biobanking services. This, in turn, has fueled growth in the biobanking market as more companies seek to enter this expanding field and meet the growing demand for cord blood stem cell preservation.

The blood products segment accounted for the largest share, by sample type in the biobanking market in 2022.

Based on sample type, the global biobanking market has been segmented into blood products, human tissues, nucleic acids, human waste products, cell lines, and biological fluids. The blood products segment held the largest share of the global biobanking market in 2022. This can be attributed to the rising incidence of blood disorders and the increasing demand for various types of blood products across the globe. With the ongoing expansion of biobanks and the increasing emphasis on precision medicine, the demand for blood products in biobanking is expected to remain strong, further propelling the growth of the global biobanking market

The manual storage segment accounted for the largest share of the storage type segment in the biobanking industry in 2022.

Based on storage, the global biobanking market has been segmented into manual storage and automated storage. The manual storage segment held the larger market share in 2022. The large share of this segment can be attributed to the low cost and easy installation associated with this type of storage. Furthermore, many research centers and life science companies rely on manual processes for biological sample storage, this is further accelerating the market growth.

The North America region catered the largest share of the biobanking market in 2022.

The biobanking market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory. This can be attributed to the increasing number of biobanks and the growing investments in biobanking infrastructure. Major healthcare institutes and research organizations in North America have made substantial commitments to expanding their biobanking capabilities. Additionally, the rising prevalence of chronic diseases and the subsequent demand for personalized medicine has fueled the growth of the biobanking market in North America, with biobanks playing a pivotal role in storing and providing high-quality biological specimens for research and development purposes.

Key players in the biobanking market include Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US).

Request 10% Customization

Biobanking Market: Impact Analysis

 Drivers

Growing investments and funding for biobanks

Focus on genetic testing and precision medicine

Increasing trend in preservation of cord blood stem cells from newborns

Favorable funding scenario for research related to regenerative medicine

 Restraints

High cost of automated equipment

Issues related to biospecimen sample management

OPPORTUNITIES

Challenges

High operational cost of biobanks

Storage of samples

Recent Developments

In February 2023, PHC Corporation of North America launched the PHCbi Brand VIP ECO SMART Ultra-low Temperature Freezer with industry-leading energy efficiency.

In September 2022, Cryoport entered into a strategic partnership with BioLife Plasma Services to offer supply chain solutions and service offerings, such as bioservices and cryo-processing, for BioLife Plasma Services.

Biobanking Market Advantages:

Valuable Research Resources: Biobanks provide researchers with access to a vast collection of well-characterized biological samples and associated data. These resources serve as a valuable foundation for conducting various types of research, including genomics, proteomics, metabolomics, and epidemiological studies. Biobanks enable researchers to investigate diseases, discover new biomarkers, study genetic variations, and develop personalized therapies.

Accelerating Drug Discovery and Development: Biobanks play a crucial role in the drug discovery and development process. By providing researchers and pharmaceutical companies with access to diverse and representative samples, biobanks facilitate the identification of drug targets, testing of potential therapies, and assessment of drug efficacy and safety. This accelerates the drug development timeline, reduces costs, and enhances the success rate of clinical trials.

Facilitating Personalized Medicine: Biobanks contribute to the advancement of personalized medicine, which aims to provide tailored healthcare based on an individual's unique genetic makeup and other factors. By storing genetic information, clinical data, and biological samples, biobanks enable the identification of genetic markers associated with diseases, predicting disease risks, and guiding personalized treatment decisions. This helps healthcare providers deliver targeted therapies and improve patient outcomes.

Long-Term Sample Preservation: Biobanks employ specialized techniques and infrastructure to ensure the long-term preservation of biological samples. This enables the availability of high-quality samples over extended periods, allowing researchers to conduct longitudinal studies, analyze disease progression, and investigate long-term health outcomes. Long-term sample storage also enables retrospective studies and future research on emerging diseases or new research questions.

Collaboration and Data Sharing: Biobanks promote collaboration and data sharing among researchers, institutions, and industries. By establishing standardized protocols, ethical guidelines, and data sharing agreements, biobanks facilitate the exchange of samples, data, and knowledge. This collaboration fosters scientific discoveries, enables the replication of research findings, and maximizes the utility of stored samples.

Advancing Translational Research: Biobanks bridge the gap between basic research and clinical applications by facilitating translational research. By linking biological samples to clinical data, biobanks support the investigation of disease mechanisms, biomarker discovery, and the development of diagnostic tests. This enhances the translation of scientific knowledge into clinical practice, leading to improved disease diagnosis, prognosis, and treatment.

Overall, the biobanking market offers significant advantages by providing researchers and healthcare professionals with access to diverse, well-preserved, and well-characterized biological samples. These advantages accelerate research, drug development, and personalized medicine initiatives, ultimately contributing to advancements in healthcare and patient care.

Biobanking market - Report Highlights:

The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall biobanking industry.

The new edition includes the impact of the recession on the biobanking market (especially the region-wise impact in the geographic analysis section) in 2022. There is a variation in the growth rate of the market due to the ongoing recession.

Additional points such as ranges/scenarios, trends/disruptions impacting customers' businesses, pricing analysis, value chain analysis, supply chain analysis, ecosystem analysis, patent analysis, key conferences and events (2022-2023), list of key regulatory bodies, regulatory landscape, Porter's Five Forces analysis, key stakeholders, the influence of stakeholders on buying decisions, and buying criteria among end users have been added in the market overview chapter.

The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This will help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.

Recent developments help us to understand market trends and the growth strategies adopted by players in the market.

Tracking the portfolios of prominent market players helps analyze the major products in the biobanking market. The new edition of the report provides an updated product portfolio of the companies profiled in the report.

Key market strategies/right to win, market share analysis for 2022, revenue share analysis of key market players from 2020 to 2022, and competitive leadership mapping have been added in the competitive landscape section of the report.

The new version of the report includes competitive leadership mapping for companies operating in the market. This new section is an output of a comprehensive study of the key vendors offering biobanking products. The top 25 vendors were shortlisted from a list of 50+ vendors, and these were evaluated based on market share/ranking and product footprint, rated and positioned on a 2x2 quadrant, referred to as Company Evaluation Quadrant, categorizing them as Stars, Emerging Leaders, Pervasive Players, and Participants.

The new version of the report includes the startup/SME evaluation quadrant for 10 companies operating in the biobanking market. This updated section is an output of a comprehensive study of the key startup vendors offering biobanking products. The top 10 vendors were shortlisted from a list of 50+ vendors, and these vendors were evaluated based on their product portfolio and business strategy, rated and positioned on a 2x2 quadrant, referred to as Competitive Leadership Quadrant, categorizing them as Progressive Companies, Starting Blocks, Responsive Companies, and Dynamic Companies.

In the new edition of the report, the Rest of the World is segmented into Latin America and the Middle East and Africa. Country-level markets for Brazil and the Rest of Latin America in the Latin American region have been added.

The new version of the report includes the ownership segment, which is further segmented into national/regional agencies, non-profit organizations, universities, and private organizations.

The new version of the report includes an end-user segment, which is further segmented into pharmaceutical & biotechnology companies and CROs, academic and research institutes, and hospitals.

Report Link: ( Biobanking Market )

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email : sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biobanking-devices-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/biobanking-devices.asp

[iruchakalyan]

The Global Cord Blood Banking Services Market was valued at USD 33.8 Billion in 2023 and is estimated to reach USD 65.9 Billion by 2033, growing at a CAGR of 7.9 % from 2024 to 2033

Cord Blood contains a very rich source of stem cells that can treat more than 80 diseases. This is the process of collecting life-saving stem cells placenta and umbilical cord and storing them for future use. These stem cells can be used in treating chronic diseases such as blood disease, cancer, diabetes, immune disease, and genetic disorders. These cells are mainly collected from hospitals, and nursing homes and are stored in a cord blood bank for future use up to 25 years. The government has taken the initiative to support research and clinical trials of cord blood stem cells, this support is driving the interest of investment from healthcare companies and commercialization of cord blood stem cell therapies. Moreover, the rise in autoimmune diseases and rising awareness of therapeutics of stem cells are propelling the growth of the market.

The technical improvement in stem cell research and development, storage procedure, and cryopreservation techniques is giving new opportunities to key players to invest in this Cord Blood Banking Service Market.

Furthermore, the rising prices for storing cord blood banking may restrict the market. A patient has to pay for storing and maintenance charges yearly and health insurance companies do not cover cord blood banking which hinders the growth of the market to expand in the forecast period. In 2022, FemiCord group said that within Europe the number of cord banks had dropped by more than 1/3rd over the past decade.

The rising awareness of cord blood stem cell therapy are major factor that drives the market growth. For instance, the automated processing and storage of cord blood has improved the cost and customer convenience.

Economic Impact of Covid-19:

The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pan\demic era of the Global Cord Blood Banking Services Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.

The COVID-19 outbreak has affected the growth of this market due to the lockdown and this delay in the supply and collection of cord blood that is used to treat disease.  The number of chronic patients increasing day by day is the major restraining factor of the Cord Blood Banking Services Market.

Key Players:

LifeCell

StemCyte Inc.

BrainStorm Cell Limited

Celgene Corporation

Cryo-Cell International

Cordlife Group Limited

Singapore Cord Blood Bank

Cryo-Save Group AV

Cord Blood America Inc.

CBR Systems Inc.

ViaCord Inc

China Cord Blood Corporation

AMAG Pharmaceuticals Inc.

Americord Registry LLC

Esperite N.V.

Others

Know More- https://nexbindinsight.com/pharmaceutical-and-healthcare/the-global-cord-blood-banking-services-market-was-valued-at

[themarketinsights]

Stem Cell Banking Market to See Major Growth by 2028

Latest released the research study on Global Stem Cell Banking Market, offers a detailed overview of the factors influencing the global business scope. Stem Cell Banking Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Stem Cell Banking The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Cord Blood Registry Systems (United States), Cordlife (Singapore), Cryo-Cell International (United States), Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands), LifeCell International (India), StemCyte (United States), ViaCord (A Subsidiary of Perkinelmer) (United States), Global Cord Blood (China) , Smart Cells International Ltd. (United Kingdom), Vita 34 International (Germany),

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/20849-global-stem-cell-banking-market

Stem Cell Banking Market Definition:

Stem cell banking is the extraction, processing, and storage of stem cells, so that they may be used for treatment in the future when required. Stem Cells have the amazing power to transform into any tissue or organ in the human body. Stem cells have a unique characteristic & the potential to treat over 80 life-threatening diseases and offers numerous benefits to the baby, its siblings and the family. Furthermore, it is being extensively used in personalized banking, research, and clinical applications.

Market Trend:

Rapid Advancements in Biotechnology Field

Market Drivers:

Growing Awareness of the Therapeutic Potential of Stem Cells

Development of Novel Technologies for Stem Cell Preservation, Processing, and Storage

Increase in HematopOIEtic Stem Cell Transplantation Procedures

Increasing Investments in Stem Cell-Based

Market Opportunities:

Emerging Countries

Rising Global Burden of Major Diseases

 

The Global Stem Cell Banking Market segments and Market Data Break Down are illuminated below:

by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Others), Application (Personalized Banking Applications, Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery}, Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}), Service (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Source (Placental Stem Cells (PSCs), Human Embryo-derived Stem Cells (hESCs), Bone Marrow-derived Stem Cells (BMSCs), Adipose Tissue-derived Stem Cells (ADSCs), Dental Pulp-derived Stem Cells (DPSCs), Other Stem Cell Sources)

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/20849-global-stem-cell-banking-market

Strategic Points Covered in Table of Content of Global Stem Cell Banking Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Stem Cell Banking market

Chapter 2: Exclusive Summary – the basic information of the Stem Cell Banking Market.

Chapter 3: Displayingthe Market Dynamics- Drivers, Trends and Challenges of the Stem Cell Banking

Chapter 4: Presenting the Stem Cell Banking Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying market size by Type, End User and Region 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Stem Cell Banking market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2021-2026).

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Stem Cell Banking Market is a valuable source of guidance for individuals and companies in decision framework.

Data Sources & Methodology The primary sources involves the industry experts from the Global Stem Cell Banking Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

For Early Buyers | Get Up to 20% Discount on This Premium Report: https://www.advancemarketanalytics.com/request-discount/20849-global-stem-cell-banking-market

What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837